However, such preliminary hypotheses remain to be proven: we have initiated specific functional studies evaluating the correlation between cetuximab sensitivity and the EGFR exon 13 genotype in various CRC cell lines and in cellular models expressing wild type EGFR or the EGFR R521K variant. The gene discussed is EGFR; the disease is colorectal carcinoma.